Clinical Oncology - Issue 6/2021
Editorial
423
Editorial
doc. MUDr. Doležel Jan, Ph. D
Review
428
Waldenström macroglobulinemia
K. Baďurová, J. Gregorová, M. Vlachová, M. Krejčí, S. Ševčíková
434
Erdheim-Chester disease
M. Brychtová, M. Vlachová, J. Gregorová, M. Krejčí, Z. Adam, S. Ševčíková
440
455
463
Polymorphisms rs4673 and rs28714259 in predicting anthracycline-mediated cardiotoxicity in patients with breast cancer
D. Y. Gvaldin, N. N. Timoshkina, L. Y. Vladimirova, Y. V. Svetitskaya, L. S. Vaschenko
467
Incidence, mortality and survival of bladder neoplasms in the Czech Republic in the period 1977–2017: a time trend analysis
L. Pehalova, D. Krejčí, T. Büchler, J. Janošek, L. Dušek
477
Primary breast lymphoma – a case report
W. Rajabto, Y. K. Angkasa, A. S. Harahap, M. F. Ham, B. Brahma
481
Recommendation for preventive and therapeutic skin care of patients undergoing radiotherapy
J. Cvek, S. Vokurka, E. Hajnová Fukasová, L. Krupová, P. Šimonová, M. Žemličková, M. Jedličková, K. Jirsová, P. Šlampa, M. Doležel, L. Hynková
488
Anotace knihy
doc. MUDr. Trna Jan, Ph.D.
Drug Profile
492
Účinnost a bezpečnost entrektinibu při léčbě nádorů s genovou fúzí NTRK
A. Rozsypalová, T. Büchler
Clinical Oncology
2021 Issue 6
Most read in this issue
- Waldenström macroglobulinemia
- Erdheim-Chester disease
- Advanced stages of classical Hodgkin lymphoma – first-line treatment options
- Recommendation for preventive and therapeutic skin care of patients undergoing radiotherapy